Alberto Nobili

Alberto Nobili is a seasoned professional with extensive experience in the biotechnology and cell therapy sectors. Currently serving as the Senior Director of Strategy & Portfolio at Bayer's CGT Co.Lab since February 2023, Alberto also holds multiple leadership roles as Co-Founder & Advisor and Co-Founder & Scientific Director at Dynamic Cell Therapies, Inc., and as Co-Founder & Vice President and Board Member at 42N Advisors. Active in the investment community, Alberto is a member of Mass Medical Angels. Previous roles include a research fellow position at Dana-Farber Cancer Institute, where Alberto contributed significantly to the development of next-generation CAR T cell platforms for cancer treatment. Alberto's academic background includes a PhD from Universität Greifswald, with research focused on the directed evolution of enzymes, and a degree in Industrial Biotechnology from Università degli Studi di Milano-Bicocca.